TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pro Health Pharma Sweden AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
21,865
|
18,346 | |
| Financial expenses |
170
|
7 | |
| Earnings before taxes |
671
|
1,067 | |
| EBITDA |
841
|
1,547 | |
| Total assets |
16,626
|
12,015 | |
| Current assets |
13,879
|
10,508 | |
| Current liabilities |
6,393
|
2,943 | |
| Equity capital |
10,028
|
8,881 | |
| - share capital |
101
|
95 | |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
60.3%
|
73.9% | |
| Turnover per employee |
7,288
|
6,115 | |
| Profit as a percentage of turnover |
3.1%
|
5.8% | |
| Return on assets (ROA) |
5.1%
|
8.9% | |
| Current ratio |
217.1%
|
357.1% | |
| Return on equity (ROE) |
6.7%
|
12.0% | |
| Change turnover |
2,218
|
1,438 | |
| Change turnover % |
14%
|
11%
|
9% |
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0%
|
50% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.